4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-14-062355
Director sold 100,000 shares at $0.24 ($24,100)
- Director acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2014-10-20 | Option exercise | +100,000 | $0.04 | $3,500 | 1,493,631 | D: show line 1 in the form |
| Kraus Al Director | 2014-10-20 | Sale | −100,000 | $0.24 | $24,100 | 1,393,631 | D: show line 2 in the form |
| Open-market sales · 100,000 sh · avg $0.24 · $24,100 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2014-10-20 | Option exercise · Stock Option | −100,000 | 5,919,328 | D: show line 3 in the form |
Loading xslF345X03/v391797_4.xml…